Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Large Granular Lymphocytosis and Its Impact on Long Term Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: 14-Year Follow-up Data

Guldane Cengiz Seval, Atilla Uslu, MD, Ekin Kircali, Sinem Civriz Bozdag, MD, Klara Dalva, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Pervin Topcuoglu, MD, Isinsu Kuzu, Onder Arslan, Muhit Özcan, Taner Demirer, MD, Osman Ilhan, MD, Hamdi Akan, MD, Meral Beksac, MD, Gunhan Gurman, MD

Blood (2019) 134 (Supplement_1): 2019.

https://doi.org/10.1182/blood-2019-128750

Published: 2019

Journal Articles

Next Generation Sequencing May be Helpful in Designing Novel Combinations Among Heavily Pretreated Myeloma Patients, Refractory to All Available Approved Anti-Myeloma Drugs

Guldane Cengiz Seval, Isinsu Kuzu, Seher Yuksel, Gulsah Kaygusuz, Klara Dalva, MD, Muhit Ozcan, Meral Beksac, MD

Blood (2019) 134 (Supplement_1): 3197.

https://doi.org/10.1182/blood-2019-127541

Published: 2019

Journal Articles

Residual Clonal Plasma Cells Detected By Flow Cytometry at 10 -4 level within Autologous Stem Cell Grafts Is Associated with Significantly Less Overall Survival

Guldane Cengiz Seval, Klara Dalva, MD, Sule Mine Bakanay, Mustafa Merter, MD, Ugur Sahin, MD, Atilla Uslu, MD, Cemaleddin Ozturk, Osman Ilhan, MD, Meral Beksac, MD

Blood (2018) 132 (Supplement 1): 3438.

https://doi.org/10.1182/blood-2018-99-111794

Published: 2018

Journal Articles

KIR 2DS4 May Influence Autologous and Cord Blood(CB) Natural Killer (NK)Cell Mediated in Vitro Cytotoxicity Against Freshly Isolated Human Bone Marrow Myeloma Plasma Cells and Cell Lines

Pinar Yurdakul Mesutoglu, Dr., Hasan Yalim Akin, MSc, Merve Bunsuz, MSc, Eylul Turasan, MSc, Mustafa Merter, MD, Cemalettin Ozturk, MD, Klara Dalva, MD, Meral Beksac, MD

Blood (2018) 132 (Supplement 1): 1920.

https://doi.org/10.1182/blood-2018-99-112837

Published: 2018

Journal Articles

Comparision of Outcomes According to HLA Disparity in Acute Leukemia Patients: A Single Center Institution Experience

Pervin Topcuoglu, MD, Guldane Cengiz Seval, Sinem Civriz Bozdag, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Klara Dalva, MD, Onder Arslan, MD, Muhit Özcan, Taner Demirer, MD, Osman Ilhan, MD, Meral Beksac, MD, Gunhan Gurman, MD

Blood (2018) 132 (Supplement 1): 5776.

https://doi.org/10.1182/blood-2018-99-120166

Published: 2018

Journal Articles

A Preliminary Analysis of Inherited Immune Checkpoint Control in Multiple Myeloma: Relative Frequency of Inhibitory or Activating Type Killer Immunoglobulin like Receptors and Their Cognate Ligands HLA-C1 and -C2

Meral Beksac, MD, Pinar Yurdakul, MSc,PhD, H.Yalim Akin, MsC, Gözde Aydin, MSc, Merve Bunsuz, MSc, Ugur Sahin, MD, Mustafa Merter, MD, Klara Dalva, MD

Blood (2017) 130 (Supplement 1): 4977.

https://doi.org/10.1182/blood.V130.Suppl_1.4977.4977

Published: 2017

Journal Articles

Preliminary Results Of A Mass Spectrometry Based Bottom Up Proteomic Approach On Bone Marrow Plasma Cells From Patients With Multiple Myeloma (MM)

Beycan Ayhan, MsC PhD, Duygu Ozer Demiralp, PhD, Klara Dalva, MD, Meral Beksac, MD

Blood (2013) 122 (21): 1887.

https://doi.org/10.1182/blood.V122.21.1887.1887

Published: 2013

Journal Articles

Kiler Immunoglobulin Receptor(KIR) Ligands Are Associated with At Least Partial (HLA A03, B44) or Poorer (HLA B51, C04) Response to Thalidomide Among Patients with Multiple Myeloma Treated in Two Turkish Centers

Elif Suyani, MD, Sule Mine Bakanay, MD, Klara Dalva, MD, Ezgi Cakmak, MSc, Rauf Haznedar, MD, Gulsan Sucak, MD, Meral Beksac, MD

Blood (2012) 120 (21): 4904.

https://doi.org/10.1182/blood.V120.21.4904.4904

Published: 2012

Journal Articles

Minimal Residual Plasma Cell Content of Autulogous Grafts, Chemosensitivity to Induction or High Dose Therapy and Pre/Post Transplant PET Negativity Predict Long Term Disease Free Survival in Multiple Myeloma.

Sule Mine Bakanay, MD, Klara Dalva, MD, Berna Elif Koksoy, MD, Erol Ayyildiz, Muhit Ozcan, M.D., Osman Ilhan, MD, Meral Beksac, MD

Blood (2012) 120 (21): 3024.

https://doi.org/10.1182/blood.V120.21.3024.3024

Published: 2012

Journal Articles

Flow Cytometric Analysis of T Cell Functions in CML Patients Under Imatinib Therapy

Deniz Goren Sahin, MD, Klara Dalva, MD, Sema Meric, Gunhan Gurman, MD, Muhit Ozcan, MD, Onder Arslan, MD, Mutlu Arat, MD

Blood (2008) 112 (11): 2633.

https://doi.org/10.1182/blood.V112.11.2633.2633

Published: 2008

Journal Articles

Factors Involved in Response to Thalidomide in Myelodysplastic Syndrome: Impace of HLA and Prognostic Factors

Sule Mine Bakanay, MD, Klara Dalva, MD, Pervin Topcuoglu, MD, Sinem Civriz-Bozdag, MD, Mutlu Arat, MD, Meral Beksac, MD, Gunhan Gurman, MD

Blood (2008) 112 (11): 5079.

https://doi.org/10.1182/blood.V112.11.5079.5079

Published: 2008

Journal Articles

Two Independent Effects of Immunoglobulin-Like Receptor (KIR) Allele Matching between Siblings: Inhibitory KIR (iKIR) Mismatches Are Associated with Graft Versus Host Disease (GVHD) While Activatory KIR Matches (aKIR) and cGVHD Are Associated with Graft Versus Leukemia (GVL).

Klara Dalva, MD, Funda Gungor, Bcs, Ender Soydan Akcaglayan, MD, Meral Beksac, MD

Blood (2006) 108 (11): 2912.

https://doi.org/10.1182/blood.V108.11.2912.2912

Published: 2006

Journal Articles

A New Predictive and Prognostic Marker for De Novo AML: Peripheral Blood CD34 (pCD34) Count at Recovery Following Remission Induction (RI) Therapy (Supp. by Ankara University-2003-0809114).

Mutlu Arat, MD, Pervin Topcuoglu, MD, Meltem K. Yuksel, MD, Klara Dalva, MD, Gulhis Gultekin, MD, Gunhan Gurman, MD, Onder Arslan, MD, Muhit Ozcan, MD, Meral Beksac, MD, Nahide Konuk, MD, Akin Uysal, MD, Haluk Koc, MD, Osman Ilhan, MD

Blood (2005) 106 (11): 4517.

https://doi.org/10.1182/blood.V106.11.4517.4517

Published: 2005

Journal Articles

Interleukin-10(IL-10)1082-A and Tumor Necrosis Factor(TNF)-Alpha 238/308A Genotypes Are Associated with Earlier (Younger Than 55) Onset of Multiple Myeloma.

Meral Beksac, MD, Merih Kizil, MD, Ender A. Soydan, MD, Esin Serbest, Bcs, Klara Dalva, MD

Blood (2004) 104 (11): 4869.

https://doi.org/10.1182/blood.V104.11.4869.4869

Published: 2004

Journal Articles

Both Higher Level of (bcr,abl) Transcripts and High Hasford Risk Score Are Associated with Cytogenetic Response but Absence of Molecular Remission during First Line Use of Imatinib Mesilate(IM): A Finding Not Observed Following Use among Interferon Failures.

Selami K. Toprak, MD, Klara Dalva, MD, Dilsa Mizrak, MD, Mutlu Arat, MD, Muhit Ozcan, MD, Gunhan Gurman, MD, Osman Ilhan, MD, Meral Beksac, MD.

Blood (2004) 104 (11): 4671.

https://doi.org/10.1182/blood.V104.11.4671.4671

Published: 2004

Journal Articles

Allogeneic Hemapoietic Progenitor Cell Collection Using Four Different Cell Separators: A Retrospective Comparative Analysis.

Mutlu Arat, MD, Onder Arslan, MD, Ender A. Soydan, MD, Erol Ayyildiz, BcS, Klara Dalva, MD, Meltem Tol, BcS, Muhit Ozcan, MD, Günhan Gürman, MD, Taner Demirer, MD, Hamdi Akan, MD, Meral Beksac, MD, Osman Ilhan, MD

Blood (2004) 104 (11): 5009.

https://doi.org/10.1182/blood.V104.11.5009.5009

Published: 2004

NARROW

Large Granular Lymphocytosis and Its Impact on Long Term Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: 14-Year Follow-up Data

Next Generation Sequencing May be Helpful in Designing Novel Combinations Among Heavily Pretreated Myeloma Patients, Refractory to All Available Approved Anti-Myeloma Drugs

Residual Clonal Plasma Cells Detected By Flow Cytometry at 10 -4 level within Autologous Stem Cell Grafts Is Associated with Significantly Less Overall Survival

KIR 2DS4 May Influence Autologous and Cord Blood(CB) Natural Killer (NK)Cell Mediated in Vitro Cytotoxicity Against Freshly Isolated Human Bone Marrow Myeloma Plasma Cells and Cell Lines

Comparision of Outcomes According to HLA Disparity in Acute Leukemia Patients: A Single Center Institution Experience

A Preliminary Analysis of Inherited Immune Checkpoint Control in Multiple Myeloma: Relative Frequency of Inhibitory or Activating Type Killer Immunoglobulin like Receptors and Their Cognate Ligands HLA-C1 and -C2

Preliminary Results Of A Mass Spectrometry Based Bottom Up Proteomic Approach On Bone Marrow Plasma Cells From Patients With Multiple Myeloma (MM)

Kiler Immunoglobulin Receptor(KIR) Ligands Are Associated with At Least Partial (HLA A03, B44) or Poorer (HLA B51, C04) Response to Thalidomide Among Patients with Multiple Myeloma Treated in Two Turkish Centers

Minimal Residual Plasma Cell Content of Autulogous Grafts, Chemosensitivity to Induction or High Dose Therapy and Pre/Post Transplant PET Negativity Predict Long Term Disease Free Survival in Multiple Myeloma.

Flow Cytometric Analysis of T Cell Functions in CML Patients Under Imatinib Therapy

Factors Involved in Response to Thalidomide in Myelodysplastic Syndrome: Impace of HLA and Prognostic Factors

Two Independent Effects of Immunoglobulin-Like Receptor (KIR) Allele Matching between Siblings: Inhibitory KIR (iKIR) Mismatches Are Associated with Graft Versus Host Disease (GVHD) While Activatory KIR Matches (aKIR) and cGVHD Are Associated with Graft Versus Leukemia (GVL).

A New Predictive and Prognostic Marker for De Novo AML: Peripheral Blood CD34 (pCD34) Count at Recovery Following Remission Induction (RI) Therapy (Supp. by Ankara University-2003-0809114).

Interleukin-10(IL-10)1082-A and Tumor Necrosis Factor(TNF)-Alpha 238/308A Genotypes Are Associated with Earlier (Younger Than 55) Onset of Multiple Myeloma.

Both Higher Level of (bcr,abl) Transcripts and High Hasford Risk Score Are Associated with Cytogenetic Response but Absence of Molecular Remission during First Line Use of Imatinib Mesilate(IM): A Finding Not Observed Following Use among Interferon Failures.

Allogeneic Hemapoietic Progenitor Cell Collection Using Four Different Cell Separators: A Retrospective Comparative Analysis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only